Novonix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	78.71	142.74	102.6	28.14
Cash & Cash Equivalents	78.71	142.74	102.6	28.14
Cash Growth	-44.85%	39.12%	264.67%	-
Receivables	3.56	2.45	1.63	0.78
Inventory	2	1.87	2.09	0.99
Other Current Assets	4.87	15.16	1.91	0.11
Total Current Assets	89.15	162.22	108.23	30.02
Property, Plant & Equipment	144.28	111.56	31.62	11.21
Long-Term Investments	16.67	16.67	0	0
Goodwill and Intangibles	11.99	12.36	12.45	13.32
Other Long-Term Assets	1.25	0.17	0.02	0.02
Total Long-Term Assets	174.19	140.76	44.08	24.54
Total Assets	263.34	302.98	152.31	54.56
Accounts Payable	5.76	6.53	3.27	2.53
Deferred Revenue	3.29	3	0.23	0.07
Current Debt	1.69	1.35	0.52	0.3
Other Current Liabilities	-2.89	-3	0	-0
Total Current Liabilities	7.84	7.89	4.02	2.91
Long-Term Debt	67.7	40.96	9.84	3.42
Other Long-Term Liabilities	3.87	3	0	0
Total Long-Term Liabilities	71.57	43.96	9.84	3.42
Total Liabilities	79.41	51.85	13.86	6.33
Total Debt	69.39	42.31	10.36	3.72
Debt Growth	64.00%	308.53%	178.34%	-
Retained Earnings	-184.85	-110.74	-58.88	-46.3
Shareholders' Equity	183.94	251.13	138.45	48.24
Net Cash / Debt	9.33	100.43	92.24	24.41
Net Cash / Debt Growth	-90.71%	8.87%	277.82%	-
Net Cash Per Share	0.02	0.22	0.25	0.18
Working Capital	81.31	154.33	104.21	27.11
Book Value Per Share	1.51	2.16	1.51	1.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).